Video

Terri E. Weaver, PhD, RN, on Efficacy of Solriamfetol for Treating Symptoms of Obstructive Sleep Apnea

01/14/2021

In this video, Terri E. Weaver, PhD, RN, talks about the effectiveness of solriamfetol in improving daily functioning, reducing daytime sleepiness, and enhancing work productivity.

Additional Resource:

Terri E. Weaver, PhD, RN, is dean and professor in the Department of Behavioral Nursing Science in the College of Nursing and professor in the Division of Pulmonary, Critical Care, Sleep, and Allergy in the Department of Medicine in the College of Medicine at the University of Illinois at Chicago.

TRANSCRIPT:

My name is Terri Weaver, I am Dean and professor at the University of Illinois Chicago College of Nursing.

This was a study to look at the effectiveness as opposed to the efficacy of solriamfetol with particular outcomes of daily functioning, daytime sleepiness, and also work productivity, along with perception of change by the patient and also the clinician.

It is approved for daytime sleepiness and patients with obstructive sleep apnea. It’s also approved for the treatment of sleepiness and narcolepsy. It is approved for 3 doses—75 mg, 150 mg, and 300 mg.

The findings showed that when this was evaluated, especially with a withdrawal phase that included a placebo, that the efficacy of solriamfetol was maintained long term, 40 weeks out.

So, the initial studies with clinical trial that was done to prove efficacy of solriamfetol showed that it was efficacious for daytime sleepiness, daily functioning, and work productivity. This study showed that efficacy was maintained long term, which was clinical effectiveness. And so, it has both efficacy and effectiveness

A component of the study was a withdrawal phase where individuals who were on doses that treated their sleepiness, when you withdrew that, in fact, they were still able to see the benefit in several outcomes that were the case with regard to the initial evaluation of the agent and that those who were placed on placebo during that time had a decline.

Thank you for the opportunity to share our work, greatly appreciate it.

Related Content

Primary Care
Primary Care
Barak Gaster, MD, on How to Identify MCI for Early Intervention
09/28/2020
In this 2-minute video, Barak Gaster, MD, talks about identifying mild cognitive impairment in primary care, a topic he is also speaking about at our Practical Updates in Primary Care 2020 Virtual Series on...
09/28/2020
Pulmonology
MeiLan K. Han, MD, MS
Pulmonology
MeiLan K. Han, MD, MS, on When to Order Imaging to Identify Patients At Risk for Disease Progression to COPD — And When to Not
08/19/2016
In this video, MeiLan K. Han, MD, MS, explains her decision-making process for determining the risk/reward of performing imaging for the identification of COPD, calling it a "delicate balance." It is a...
08/19/2016
Gastroenterology
Gastroenterology
AIBD2016_CLINICAL_07_lichtenstein
08/01/2018
08/01/2018
Stress and Burnout
Stress and Burnout
How I Practice Now: Tips for Staying Focused Through the Pandemic
02/04/2020
In this video, Nutrition411 advisory board member Lisa Jones, MA, RDN, LDN, FAND, discusses the challenges of staying focused during the pandemic, and strategies to keep calm and carry on.
02/04/2020
Hypertension
George Bakris
Hypertension
Dr. George Bakris on Implications of Current Guidelines for Diabetes and Hypertension Management
11/08/2018
Dr George Bakris from the Comprehensive Hypertension Center discusses the implications of current guidelines on patients with co-existing diabetes and hypertension.
11/08/2018